| Market Cap | ₹475Cr |
| ROE | -17.19% |
| P/E Ratio(TTM) | -1.32 |
| EPS(TTM) | -16.12 |
| P/B Ratio | 0.66 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.18 |
| Book Value | 31.97 |
| Debt to Equity | 0.64 |
| Face Value | 1 |
| Parent Organisation | Nectar Life Sciences |
| Managing Director | Mr. Sanjiv Goyal |
| NSE Symbol | NECLIFE |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.94 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.07 | ||
| Wockhardt | NA (0.00%) | -439.39 | ||
| Cohance Lifesciences | NA (0.00%) | 64.75 |